| Filed On | Filing |
|---|---|
| 21 Mar 2022 |
Form 3: Kaye Randall, CMO
No securities owned |
| 17 Nov 2021 |
Form 3: Tiller Jane, Director
No securities owned |
| 11 Mar 2021 |
Form 3: Arena Pharmaceuticals Inc, 10% owner
Holds 3,840,540 shares of Voting Common Stock |
| 11 Mar 2021 |
Form 3: Le Goff Corinne, Director
No securities owned |
| 11 Mar 2021 |
Form 3: Lynch Casey, Director
No securities owned |
| 11 Mar 2021 | Form 3: Sekhri Paul J, Director |
| 11 Mar 2021 | Form 3: Schneider Phillip M, Director |
| 11 Mar 2021 |
Form 3: Aurentz Vincent, Director
No securities owned |
| 11 Mar 2021 | Form 3: Roberts Brandi, Chief Financial Officer |
| 11 Mar 2021 | Form 3: Perera Philip, Chief Medical Officer |
| 11 Mar 2021 |
Form 3: Lind Kevin Robert, Director
Holds 348,450 shares of Voting Common Stock |
Loading...